FDA issued a Warning Letter to Samson Pharmaceuticals, Inc. on 12/13/2018 as a result of this inspection.
483 Samson Pharmaceuticals Feb 2018

483 Samson Pharmaceuticals Feb 2018

Santiago Gallardo Johnson FDA, Jolanna Norton FDA$119.00 - Available Now

FDA investigators audited the Samson Pharmaceuticals - Commerce, CA, United States facility and issued inspectional observations (via FDA 483) on 09 Feb 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 09 Feb 2018
  • Location: Commerce, United States
  • FEI: 3005644727
Add To Cart